Randomized trial of non-surgical therapy and oral hygiene instruction to reduce risk of infective endocarditis
Ended Cooperative Agreement Awarded Last action
- Award ID
- UG3DE031250
- Recipient
-
The Charlotte-Mecklenburg Hospital Authority UEI LCSFK2KRP5A4
- Awarding agency
-
National Institute of Dental and Craniofacial Research
National Institutes of Health, Department of Health and Human Services
- Obligated
- $555,803
Award facts
- Assistance listing
- 93.121 Oral Diseases and Disorders Research
- Completion date
- Place of performance
- Charlotte, NC 28203, USA
Award details come from USAspending.gov.
Description
- Abstract
- Infective endocarditis (IE) has high morbidity and mortality. Upwards of 30% of cases of IE are caused by oral bacterial species that enter the bloodstream and colonize heart valves. Frequent episodes of bacteremia from dental biofilm (PLAQUE) are likely to be significant risk factors for development of IE. Our prior work demonstrates that: 1) there are only informal guidelines for prevention in 90% of people at risk for IE; 2) tooth brushing results in a high incidence of bacteremia of IE-causing species; 3) the risk of such bacteremia increases with the level of dental PLAQUE and calculus present; and 4) patients with IE have a higher burden of dental PLAQUE and calculus than matched non-IE controls. Although millions of people in the U.S. Are at risk for IE because of pre-existing cardiac conditions, there are no prospective studies or solid evidence to show that improving oral hygiene reduces bacteremia from routine daily activities (e.g., toothbrushing). Evidence does show, however, that bacteremia is a strong surrogate marker for risk of IE. The lack of supporting data means that longstanding speculation about the importance of oral hygiene and gingival inflammation as risk factors for IE have had too little impact on practice guidelines on prevention, clinical practice, or funding for preventive care. The next step is to determine if professional scaling and oral hygiene instruction significantly reduce the incidence and duration of IE-causing bacteremia from toothbrushing. We plan to enroll 320 people at risk for IE into a clinical trial. Enrollees will be randomized to professional scaling and oral hygiene instruction versus routine oral care. We will test the steps in the hypothesized causal pathway from improved oral hygiene to decreased bacteremia from IE-causing species by: 1) determining the impact of professional scaling and oral hygiene instruction on the incidence and duration of bacteremia with IE-causing species during and following toothbrushing; 2) comparing oral hygiene and gingival health measures between randomized treatment groups and testing whether improvement in these measures is associated with reduced incidence and duration of bacteremia from toothbrushing; and 3) determining the degree to which reduction in bacteremia incidence and duration, and improvement in oral hygiene and gingival inflammation scores, are maintained following the intervention. This study will provide novel, important data to inform the healthcare community, guideline committees, and health funding agencies of the importance of improving oral hygiene and reducing gingival inflammation as primary preventive measures for all people at risk of IE.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | -$105,046 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $660,849 |
Quick answers
Who received award UG3DE031250?
UG3DE031250 was awarded to The Charlotte-Mecklenburg Hospital Authority by National Institute of Dental and Craniofacial Research (National Institutes of Health) on February 1, 2022.
How much is award UG3DE031250 worth?
$555,803 has been obligated on UG3DE031250.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award